Literature DB >> 16736108

TNF-alpha priming effect on polymorphonuclear leukocyte reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients.

Jacek Rysz1, Maciej Banach, Robert A Stolarek, Jarosław Pasnik, Aleksandra Ciałkowska-Rysz, Leszek Markuszewski, Zbigniew Baj.   

Abstract

INTRODUCTION: The study aimed to assess reactive oxygen species generation and the expressions of some surface antigens on polymorphonuclear leukocytes (PMNs) in patients on regular hemodialysis (HD) treatment.
MATERIALS AND METHODS: The respiratory burst of PMNs was determined with luminol-dependent chemiluminescence (CL) in resting cells and following N-formyl-methionyl-leucyl-phenylalanine (fMLP), phorbol 12-myristate 13-acetate (PMA), or opsonized zymosan (OZ) stimulation and expressed in arbitrary CL units times assay-time (aU x min). The expressions of CD11b/CD18, CD10, and CD13 receptors were determined with flow cytometry.
RESULTS: Basal PMN CL was increased in HD patients to up to 1285 +/- 129 aU x min compared with 895 +/- 88 aU x min in healthy controls (p < 0.05). The CL of unprimed PMNs increased after fMLP stimulation from 3085 +/- 746 to 4529 +/- 808 aU x min, and after OZ stimulation from 12945 +/- 1296 to 14678 +/- 1355 aU x min. PMA-stimulated CL of PMNs was similar to control values. The oxidative burst in PMNs from HD patients and healthy controls was similar in response to TNF-alpha alone. The CL of TNF-alpha-primed PMNs in HD patients was significantly lower than CL measured in healthy controls (p < 0.05). The expressions of CD10 and CD13 metalloproteinase receptors were also increased (p < 0.05). Although CD11b expression was significantly increased at rest and after fMLP stimulation, the expression of another beta-integrin heterodimer compound, CD18, was not increased.
CONCLUSIONS: These results provide evidence that TNF-alpha priming of PMNs is down-regulated in HD patients despite constitutive up-regulation of resting cytotoxicity and enhanced expression of adhesion and metalloproteinase receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16736108      PMCID: PMC7079744          DOI: 10.1007/s00005-006-0023-1

Source DB:  PubMed          Journal:  Arch Immunol Ther Exp (Warsz)        ISSN: 0004-069X            Impact factor:   4.291


  2 in total

1.  Serum metalloproteinases MMP-2, MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in patients on hemodialysis.

Authors:  Jacek Rysz; Maciej Banach; Robert A Stolarek; Dimitri P Mikhailidis; Aleksandra Cialkowska-Rysz; Lech Pokoca; Mariusz Piechota; Zbigniew Baj
Journal:  Int Urol Nephrol       Date:  2009-12-02       Impact factor: 2.370

2.  Evaluation of selected parameters of the antioxidative system in patients with type 2 diabetes in different periods of metabolic compensation.

Authors:  Jacek Rysz; Robert Błaszczak; Maciej Banach; Kornelia Kedziora-Kornatowska; Tomasz Kornatowski; Wojciech Tański; Józef Kedziora
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2007 Sep-Oct       Impact factor: 4.291

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.